NCT02757651View on ClinicalTrials.gov

KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 19, 2017

Primary Completion Date

November 12, 2020

Study Completion Date

November 12, 2020

Conditions
Breast Cancer
Interventions
DRUG

Hydrogen Peroxide

Hydrogen Peroxide

Trial Locations (1)

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

All Listed Sponsors
collaborator

Kortuc, Inc.

INDUSTRY

lead

Institute of Cancer Research, United Kingdom

OTHER

NCT02757651 - KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response | Biotech Hunter | Biotech Hunter